China Apheresis Equipment Market Size & Outlook, 2023-2030
China apheresis equipment market, 2018-2030 (US$M)
Related Markets
China apheresis equipment market highlights
- The China apheresis equipment market generated a revenue of USD 155.1 million in 2023 and is expected to reach USD 358.8 million by 2030.
- The China market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
- In terms of segment, disposable apheresis kits was the largest revenue generating product in 2023.
- Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Apheresis equipment market data book summary
| Market revenue in 2023 | USD 155.1 million |
| Market revenue in 2030 | USD 358.8 million |
| Growth rate | 12.7% (CAGR from 2023 to 2030) |
| Largest segment | Disposable apheresis kits |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Disposable Apheresis Kits, Devices |
| Key market players worldwide | Asahi Kasei Corp, Terumo Corp, Fresenius SE & Co KGaA, Haemonetics Corp, B. Braun, Nikkiso Co Ltd, Mallinckrodt PLC Ordinary Shares - New |
Other key industry trends
- In terms of revenue, China accounted for 5.3% of the global apheresis equipment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan apheresis equipment market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 358.8 million by 2030.
Disposable apheresis kits was the largest segment with a revenue share of 72.53% in 2023. Horizon Databook has segmented the China apheresis equipment market based on disposable apheresis kits, devices covering the revenue growth of each sub-segment from 2018 to 2030.
The apheresis equipment market in China is highly competitive. The high prevalence of thalassemia in China highlights the urgent need for comprehensive screening & genetic counseling programs and underscores the importance of well-equipped healthcare infrastructure, including apheresis equipment, to address the growing demand for blood transfusions and related therapies.
According to the Regents of the University of California article published in April 2023, thalassemia presents a significant healthcare concern in China, with substantial implications for the China apheresis equipment market. The prevalence of thalassemia in China is considerable, with over 20,000 thalassemia births estimated annually & approximately 47.48 million individuals identified as carriers of the disease.
Southern Chinese populations are particularly affected, exhibiting a higher carrier rate for alpha thalassemia (5%) and beta-thalassemia or Hb E (4%) compared to other regions. Disturbingly, one in 254 Chinese individuals carry the attribute of Hb E, with over 5 million people in China carrying the Hb E trait.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Apheresis Equipment Market Scope
Apheresis Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China apheresis equipment market size, by product, 2018-2030 (US$M)
China Apheresis Equipment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
